These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 30321081)
1. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma. Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081 [TBL] [Abstract][Full Text] [Related]
2. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061 [TBL] [Abstract][Full Text] [Related]
3. SND1 Regulates Organic Anion Transporter 2 Protein Expression and Sensitivity of Hepatocellular Carcinoma Cells to 5-Fluorouracil. Wang Y; Wang Y; Fang Y; Jiang H; Yu L; Hu H; Zeng S Drug Metab Dispos; 2024 Aug; 52(9):997-1008. PubMed ID: 38960734 [TBL] [Abstract][Full Text] [Related]
4. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077 [TBL] [Abstract][Full Text] [Related]
5. lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141. Wu L; Pan C; Wei X; Shi Y; Zheng J; Lin X; Shi L Cell Commun Signal; 2018 Aug; 16(1):47. PubMed ID: 30119680 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. Xiao JN; Yan TH; Yu RM; Gao Y; Zeng WL; Lu SW; Que HX; Liu ZP; Jiang JH J Cancer Res Clin Oncol; 2017 Jun; 143(6):981-990. PubMed ID: 28271214 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB. Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689 [TBL] [Abstract][Full Text] [Related]
9. The Pivotal Role of Long Noncoding RNA RAB5IF in the Proliferation of Hepatocellular Carcinoma Via LGR5 Mediated β-Catenin and c-Myc Signaling. Koo JI; Lee HJ; Jung JH; Im E; Kim JH; Shin N; Sim DY; Hwang J; Kim SH Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31717443 [TBL] [Abstract][Full Text] [Related]
10. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil. Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma. Sun QM; Hu B; Fu PY; Tang WG; Zhang X; Zhan H; Sun C; He YF; Song K; Xiao YS; Sun J; Xu Y; Zhou J; Fan J Carcinogenesis; 2018 Dec; 39(12):1438-1446. PubMed ID: 30169594 [TBL] [Abstract][Full Text] [Related]
12. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma. Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187 [TBL] [Abstract][Full Text] [Related]
13. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma. El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316 [TBL] [Abstract][Full Text] [Related]
14. TGF-β1 upregulates the expression of lncRNA UCA1 and its downstream HXK2 to promote the growth of hepatocellular carcinoma. Hu ML; Wang XY; Chen WM Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4846-4854. PubMed ID: 30070319 [TBL] [Abstract][Full Text] [Related]
15. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma. Sheng N; Li Y; Qian R; Li Y Biomed Pharmacother; 2018 Feb; 98():577-584. PubMed ID: 29288973 [TBL] [Abstract][Full Text] [Related]
16. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling. Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626 [TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
18. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis. Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364 [TBL] [Abstract][Full Text] [Related]
19. A novel lncRNA PLK4 up-regulated by talazoparib represses hepatocellular carcinoma progression by promoting YAP-mediated cell senescence. Jia Y; Jin H; Gao L; Yang X; Wang F; Ding H; Chen A; Tan S; Zhang F; Shao J; Wang S; Zheng S J Cell Mol Med; 2020 May; 24(9):5304-5316. PubMed ID: 32243714 [TBL] [Abstract][Full Text] [Related]
20. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]